Adenosine promotes alternative macrophage activation via A2A and A2B receptors
暂无分享,去创建一个
Pal Pacher | W. Gause | P. Murray | Z. Nemeth | P. Pacher | S. Leibovich | G. Haskó | György Haskó | Peter J. Murray | Balázs Csóka | Zsolt Selmeczy | Balázs Koscsó | Zoltán H. Németh | Diane Kepka‐Lenhart | Sidney M. Morris Jr. | William C. Gause | S. Joseph Leibovich | Z. Selmeczy | B. Csóka | Balázs Koscsó | D. Kepka‐Lenhart | Sidney M. Morris Jr.
[1] Jeffrey M. Wilson,et al. The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells 1 , 2009, The Journal of Immunology.
[2] J. Schittenhelm,et al. Cutting Edge: A2B Adenosine Receptor Signaling Provides Potent Protection during Intestinal Ischemia/Reperfusion Injury1 , 2009, The Journal of Immunology.
[3] U. Yamashita,et al. Reduced expression of STAT4 and IFN-gamma in macrophages from BALB/c mice. , 2002, Journal of immunology.
[4] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[5] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[6] Pál Pacher,et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.
[7] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[8] M. Koupenova,et al. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. , 2006, The Journal of clinical investigation.
[9] Dan Yang,et al. Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury. , 2009, Experimental hematology.
[10] M. Mirabet,et al. IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. , 1999, Journal of immunology.
[11] G. Kaplan,et al. Arginine Usage in Mycobacteria-Infected Macrophages Depends on Autocrine-Paracrine Cytokine Signaling , 2010, Science Signaling.
[12] P. De Baetselier,et al. Alternatively activated macrophages during parasite infections. , 2004, Trends in parasitology.
[13] K. Jacobson,et al. Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.
[14] J. Albina,et al. MACROPHAGE ARGINASE REGULATION BY CCAAT/ENHANCER-BINDING PROTEIN β , 2005, Shock.
[15] W. Calhoun,et al. Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[16] M. Blackburn,et al. Adenosine receptors and inflammation. , 2009, Handbook of experimental pharmacology.
[17] Kyu-Earn Kim,et al. Upregulation of MUC5AC gene expression by IL‐4 through CREB in Human airway epithelial cells , 2009, Journal of cellular biochemistry.
[18] E. Vizi,et al. A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. , 2007, Blood.
[19] B. Sperlágh,et al. Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. , 2004, Biochemical and biophysical research communications.
[20] E. Vizi,et al. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. , 1996, Journal of immunology.
[21] N. Rosenthal,et al. A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair , 2009, Proceedings of the National Academy of Sciences.
[22] U. Yamashita,et al. Reduced Expression of STAT4 and IFN-γ in Macrophages from BALB/c Mice1 , 2002, The Journal of Immunology.
[23] E. Vizi,et al. A2B Adenosine Receptors Protect against Sepsis-Induced Mortality by Dampening Excessive Inflammation , 2010, The Journal of Immunology.
[24] M. Pelletier,et al. Molecular mechanisms involved in interleukin‐4‐induced human neutrophils: expression and regulation of suppressor of cytokine signaling , 2007, Journal of leukocyte biology.
[25] E. Vizi,et al. A(2B) adenosine receptors in immunity and inflammation. , 2009, Trends in immunology.
[26] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[27] S. Morris,et al. Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta. , 2005, Gene.
[28] G. Kaplan,et al. Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens , 2008, Nature Immunology.
[29] M. Sitkovsky,et al. Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. , 2005, Nature reviews. Immunology.
[30] Z. Ge,et al. Adenosine Inhibits Tumor Necrosis Factor-α Release from Mouse Peritoneal Macrophages via A2A and A2B but Not the A3 Adenosine Receptor , 2005, Journal of Pharmacology and Experimental Therapeutics.
[31] G. Freund,et al. IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCdelta. , 2004, Cellular signalling.
[32] D. Mullins,et al. Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.
[33] B. Dahal,et al. Macrophage galactose‐type C‐type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation , 2005, Journal of leukocyte biology.
[34] S. Gordon,et al. Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.
[35] M. Munder,et al. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. , 1998, Journal of immunology.
[36] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[37] B. Foxwell,et al. IL-4 regulation of p38 MAPK signalling is dependent on cell type. , 2002, Cytokine.
[38] S. Vogel,et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.
[39] I Biaggioni,et al. Adenosine A2B receptors. , 1997, Pharmacological reviews.
[40] M. Caldwell,et al. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. , 1990, Journal of immunology.
[41] W. Gause,et al. Alternatively activated macrophages in helminth infections. , 2007, Current opinion in immunology.
[42] I. Biaggioni,et al. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells. , 1999, Molecular pharmacology.
[43] Atique U. Ahmed,et al. Macrophages orchestrate the immune response to tumor cell death. , 2001, Cancer research.
[44] E. Vizi,et al. Role of A2A adenosine receptors in regulation of opsonized E. coli-induced macrophage function , 2007, Purinergic Signalling.
[45] I. Biaggioni,et al. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. , 1993, Molecular pharmacology.
[46] J. Linden. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.
[47] E. Deitch,et al. Adenosine inhibits IL-12 and TNF-a production via adenosine A 2 a receptor-dependent and independent mechanisms , 2000 .
[48] A. Ohta,et al. A2B Adenosine Receptor Blockade Enhances Macrophage-Mediated Bacterial Phagocytosis and Improves Polymicrobial Sepsis Survival in Mice , 2011, The Journal of Immunology.
[49] E. Vizi,et al. Shaping of monocyte and macrophage function by adenosine receptors. , 2007, Pharmacology & therapeutics.
[50] P. Murray,et al. Enhancer-Mediated Control of Macrophage-Specific Arginase I Expression1 , 2004, The Journal of Immunology.
[51] M. Modolell,et al. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. , 1995, Biochemical and biophysical research communications.
[52] C. Szabó,et al. ADENOSINE STIMULATES CREB ACTIVATION IN MACROPHAGES VIA A P38 MAPK‐MEDIATED MECHANISM: 165 , 2003 .
[53] Geert Raes,et al. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. , 2006, Immunobiology.
[54] John S. Welch,et al. TH2 Cytokines and Allergic Challenge Induce Ym1 Expression in Macrophages by a STAT6-dependent Mechanism* , 2002, The Journal of Biological Chemistry.
[55] E. Vizi,et al. Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism1 , 2005, The Journal of Immunology.
[56] T. Wynn,et al. Obstacles and opportunities for understanding macrophage polarization , 2011, Journal of leukocyte biology.
[57] I. Biaggioni,et al. Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory Cytokines , 2008, Journal of Pharmacology and Experimental Therapeutics.
[58] I. Biaggioni,et al. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. , 1998, Biochemical pharmacology.